HealthcareServices

Global Preimplantation Genetic Testing Market Report 2026–2030: Data-Driven Growth Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the preimplantation genetic testing market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Preimplantation Genetic Testing Market be in 2030 compared with 2026?

The preimplantation genetic testing market has seen significant expansion in recent years. It is forecast to grow from $0.92 billion in 2025 to $1.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.4%. The growth observed in the past can be attributed to several factors, including the increasing application of assisted reproductive technologies, improvements in embryo biopsy techniques, a heightened awareness regarding the prevention of genetic diseases, the expansion of fertility clinics, and better success rates for IVF.

The preimplantation genetic testing market is projected for significant expansion in the coming years, reaching $1.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.1%. This anticipated growth stems from several factors, including the escalating demand for personalized reproductive medicine, the expanding embrace of cutting-edge genomic technologies, the broadening of fertility preservation services, a rise in investment within reproductive health infrastructure, and a greater regulatory acceptance of genetic screening. Key trends foreseen during this period involve a greater uptake of embryo screening procedures, an increased application of next-generation sequencing in IVF, the wider integration of genetic testing into fertility treatments, a heightened desire for better implantation success rates, and a sharpened emphasis on mitigating genetic disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp

What Drivers Are Guiding Growth Patterns In The Preimplantation Genetic Testing Market?

An anticipated rise in in vitro fertilization (IVF) procedures is poised to drive the expansion of the preimplantation genetic testing market in the future. IVF involves the process of fertilizing an egg with sperm externally to create an embryo, which is then transferred into the uterus. Advancements in reproductive technology, higher infertility rates, and enhanced public knowledge are fueling the rise in IVF procedures. This surge in in vitro fertilization (IVF) procedures is stimulating the preimplantation genetic testing market, as it generates greater demand for genetic screening of embryos prior to implantation. For example, the Human Fertilisation & Embryology Authority, an independent UK-based fertility treatment regulator, stated in June 2025 that 52,400 patients underwent more than 77,500 in vitro fertilization (IVF) cycles at licensed UK fertility clinics in 2023. Furthermore, egg freezing cycles grew from 4,700 in 2022 to 6,900 in 2023, representing 7% of total cycles. Consequently, the expanding number of in vitro fertilization (IVF) procedures is a key factor propelling the preimplantation genetic testing market.

How Is The Preimplantation Genetic Testing Market Divided Into Segments?

The preimplantation genetic testing market covered in this report is segmented –

1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

2) By Product: Reagents And Consumables, Instruments, Software

3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies

4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications

5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs

Subsegments:

1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)

2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation

Which Trends Are Influencing The Development Of The Preimplantation Genetic Testing Market?

Leading firms within the preimplantation genetic testing market are creating sophisticated next-generation sequencing (NGS) instruments aimed at boosting the precision, effectiveness, and swiftness of genetic screening, facilitating a broader analysis and more informed choices for future parents. These next-generation sequencing (NGS) instruments quicken genetic research through fast, high-volume examination of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). They offer in-depth understanding of genetic differences and gene activity, thereby enhancing precision and making personalized medicine possible. As an illustration, in July 2023, Thermo Fisher Scientific, a US-based biotechnology company, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, which are advanced next-generation sequencing tools developed to improve IVF and ICSI research. These assays simplify processes from sample handling to aneuploidy analysis, utilizing advanced technology on the Ion Torrent Genexus integrated sequencer. This represents a substantial step forward in the preimplantation genetic testing market by improving embryo screening and elevating success rates in assisted reproductive technologies.

Which Key Players Are Driving Competition In The Preimplantation Genetic Testing Market?

Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/preimplantation-genetic-testing-global-market-report

Which Region Is Projected To Lead The Preimplantation Genetic Testing Market During The Forecast Period?

North America was the largest region in the preimplantation genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Preimplantation Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp

Browse Through More Reports Similar to the Global Preimplantation Genetic Testing Market 2026, By The Business Research Company

Genetically Modified Animal Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetically-modified-animal-products-global-market-report

Genetically Modified Fruits Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report

Optogenetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795